Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act

Hozzl · 2023-01-11T13:48:51Z

Explore the details of House Bill 2430 Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Crime and Law Enforcement. Stay informed on legislative developments.

1/11/2023, 1:48 PM

Summary of Bill HR 2430

Bill 117 HR 2430, also known as the Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act, is a piece of legislation that aims to extend the temporary scheduling of fentanyl analogues by the Drug Enforcement Administration (DEA). Fentanyl analogues are synthetic opioids that are chemically similar to fentanyl and have been linked to a rise in overdose deaths in the United States.

The bill was introduced in response to the expiration of the temporary scheduling of fentanyl analogues, which was set to expire on February 6, 2020. The temporary scheduling allows the DEA to classify fentanyl analogues as Schedule I controlled substances, making it illegal to manufacture, distribute, or possess these substances without proper authorization.

The Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act seeks to extend this temporary scheduling for an additional 15 months, giving Congress more time to consider a more permanent solution to the issue of fentanyl analogues. The bill also includes provisions for the DEA to conduct a study on the impact of fentanyl analogues on public health and safety, as well as recommendations for how to address the issue moving forward. Overall, the Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act is a bipartisan effort to combat the opioid crisis by extending the temporary scheduling of fentanyl analogues and providing additional resources for research and prevention efforts.

Congressional Summary of HR 2430

Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act

This bill extends until May 6, 2022, the temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances in schedule I of the Controlled Substances Act. The temporary order expires on May 6, 2021.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 2430

Bill HR 2430 is currently in the status of Bill Introduced since April 8, 2021. Bill HR 2430 was introduced during Congress 117 and was introduced to the House on April 8, 2021. Bill HR 2430's most recent activity was Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. as of October 19, 2021

Bipartisan Support of Bill HR 2430

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 2430

Primary Policy Focus

Crime and Law Enforcement

Potential Impact Areas

Drug trafficking and controlled substances

Alternate Title(s) of Bill HR 2430

Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues ActTo amend the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances.Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act

Start holding our government accountable!